Search Results - Richard F. Pollock

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant. by Gorden Muduma, Rhodri Saunders, Isaac Odeyemi, Richard F Pollock

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  2. 2

    Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs by Kristin Grabe-Heyne, Christof Henne, Paramananthan Mariappan, Götz Geiges, Johannes Pöhlmann, Richard F. Pollock

    Published in Frontiers in Oncology (2023-06-01)
    Get full text
    Article


  3. 3

    Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden by Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, Andreas Kallsoy Slættanes, Mikael Svärd, Richard F. Pollock

    Published in Scientific Reports (2024-01-01)
    Get full text
    Article


  4. 4

    Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK) by Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader

    Published in Annals of Hepatology (2025-07-01)
    Get full text
    Article


  5. 5

    High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma by Johannes Pöhlmann, Michael Weller, Andrea Marcellusi, Kristin Grabe-Heyne, Lucia Krott-Coi, Silvia Rabar, Richard F. Pollock

    Published in Frontiers in Oncology (2024-03-01)
    Get full text
    Article


  6. 6

    Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France by Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lync, Stephane Roze

    Article


  7. 7

    Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada by Hamza Alshannaq, John J Isitt, Richard F Pollock, Gregory J Norman, Greg Cogswell, Peter M Lynch, Stephane Roze

    Article


  8. 8

    Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial by Manuel De la Torre-Aláez, Ana Matilla, María Varela, Mercedes Iñarrairaegui, María Reig, José Luis Lledó, Juan Ignacio Arenas, Sara Lorente, Milagros Testillano, Laura Márquez, Gemma Iserte, Josepmaria Argemí, Carlos Gómez-Martin, Macarena Rodríguez-Fraile, José I. Bilbao, Richard F. Pollock, Johannes Pöhlmann, Ion Agirrezabal, Bruno Sangro

    Published in Journal of Patient-Reported Outcomes (2025-04-01)
    Get full text
    Article


Search Tools: